Published in Brain Behav Immun on August 04, 2011
Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset. Schizophr Bull (2016) 0.81
Cognitive remission: a novel objective for the treatment of major depression? BMC Med (2016) 0.80
Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder. Brain Behav Immun (2016) 0.80
The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder. Int J Geriatr Psychiatry (2013) 0.80
Platelet-activating factors are associated with cognitive deficits in depressed coronary artery disease patients: a hypothesis-generating study. J Neuroinflammation (2014) 0.78
Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study. BMC Cancer (2014) 0.77
Impact of pharmacological and psychological treatment methods of depressive and anxiety disorders on cognitive functioning. J Neural Transm (Vienna) (2014) 0.76
Effects of Duloxetine Treatment on Cognitive Flexibility and BDNF Expression in the mPFC of Adult Male Mice Exposed to Social Stress during Adolescence. Front Mol Neurosci (2016) 0.76
Leukocyte telomere length predicts SSRI response in major depressive disorder: A preliminary report. Mol Neuropsychiatry (2016) 0.75
Metabolic Effects of Antidepressant Treatment. Noro Psikiyatr Ars (2017) 0.75
Biomarkers for depression: recent insights, current challenges and future prospects. Neuropsychiatr Dis Treat (2017) 0.75
A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. Am J Hum Genet (2002) 2.60
Developing a SNP panel for forensic identification of individuals. Forensic Sci Int (2005) 2.55
Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.56
The risk factors of Internet addiction--a survey of university freshmen. Psychiatry Res (2009) 1.52
The evolution and population genetics of the ALDH2 locus: random genetic drift, selection, and low levels of recombination. Ann Hum Genet (2004) 1.49
Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int J Neuropsychopharmacol (2008) 1.38
The distribution and most recent common ancestor of the 17q21 inversion in humans. Am J Hum Genet (2010) 1.31
A study on the sleep quality of incoming university students. Psychiatry Res (2012) 1.27
Active job, healthy job? Occupational stress and depression among hospital physicians in Taiwan. Ind Health (2010) 1.10
Study of hepatotoxicity of naltrexone in the treatment of alcoholism. Alcohol (2006) 1.09
A global view of the OCA2-HERC2 region and pigmentation. Hum Genet (2011) 1.08
Name change for schizophrenia. Schizophr Bull (2014) 1.08
Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation. Neuropsychopharmacology (2009) 1.07
Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. Alcohol Clin Exp Res (2004) 1.07
Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers--a SPECT study. Neuroimage (2007) 1.04
Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding region variation. Hum Genet (2002) 1.01
Hypomania: a transcultural perspective. World Psychiatry (2010) 0.99
Validation of the Chinese version of the hypomania checklist (HCL-32) as an instrument for detecting hypo(mania) in patients with mood disorders. J Affect Disord (2007) 0.99
Pharmacokinetic and pharmacodynamic basis for overcoming acetaldehyde-induced adverse reaction in Asian alcoholics, heterozygous for the variant ALDH2*2 gene allele. Pharmacogenet Genomics (2009) 0.98
Greater availability of dopamine transporters in patients with major depression--a dual-isotope SPECT study. Psychiatry Res (2008) 0.95
Decreased dopamine transporter availability in male smokers -- a dual isotope SPECT study. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.95
Anti-NMDA receptor encephalitis with the initial presentation of psychotic mania. J Clin Neurosci (2012) 0.94
The amygdala excitatory/inhibitory balance in a valproate-induced rat autism model. PLoS One (2013) 0.93
Psychiatric morbidity and posttraumatic symptoms among earthquake victims in primary care clinics. Gen Hosp Psychiatry (2003) 0.93
Dopamine transporter gene may be associated with bipolar disorder and its personality traits. Eur Arch Psychiatry Clin Neurosci (2014) 0.93
Calcitonin induces podosome disassembly and detachment of osteoclasts by modulating Pyk2 and Src activities. Bone (2007) 0.92
Two case studies of hypothermia induced by an increased dosage of zotepine in a combination therapy. Psychiatry Clin Neurosci (2003) 0.92
The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia. Int J Nurs Stud (2004) 0.91
Histone acetylation is essential for ANG-II-induced IGF-IIR gene expression in H9c2 cardiomyoblast cells and pathologically hypertensive rat heart. J Cell Physiol (2012) 0.91
Acetaldehyde involvement in positive and negative alcohol expectancies in han Chinese persons with alcoholism. Arch Gen Psychiatry (2006) 0.91
High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan. J Affect Disord (2009) 0.91
Monoamine oxidase-A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence. J Psychiatry Neurosci (2007) 0.90
The role of valproate in metabolic disturbances in bipolar disorder patients. J Affect Disord (2010) 0.90
Pharmacogenomics with antidepressants in the STAR*D study. Pharmacogenomics (2008) 0.90
Translational and transcriptional control of Sp1 against ischaemia through a hydrogen peroxide-activated internal ribosomal entry site pathway. Nucleic Acids Res (2011) 0.89
MAOA interacts with the ALDH2 gene in anxiety-depression alcohol dependence. Alcohol Clin Exp Res (2010) 0.89
β2-adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway. J Immunol (2011) 0.89
The interaction between BDNF and DRD2 in bipolar II disorder but not in bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet (2012) 0.88
The functionality and economic costs of outpatients with schizophrenia in Taiwan. Psychiatry Res (2008) 0.88
Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence: A SPECT study. Eur Neuropsychopharmacol (2006) 0.87
Microglial regulation of immunological and neuroprotective functions of astroglia. Glia (2014) 0.87
Correlation between fine motor activity and striatal dopamine D2 receptor density in patients with schizophrenia and healthy controls. Psychiatry Res (2003) 0.87
Low-dose memantine attenuated morphine addictive behavior through its anti-inflammation and neurotrophic effects in rats. J Neuroimmune Pharmacol (2011) 0.87
Neuropsychological functions in patients with bipolar I and bipolar II disorder. Bipolar Disord (2009) 0.87
Smoking and psychosis in patients with bipolar I disorder. Compr Psychiatry (2002) 0.87
Association of promoter variants of human dopamine transporter gene with schizophrenia in Han Chinese. Schizophr Res (2010) 0.86
Effects of C825T polymorphism of the GNB3 gene on availability of dopamine transporter in healthy volunteers--a SPECT study. Neuroimage (2011) 0.86
Association between cognitive performance and striatal dopamine binding is higher in timing and motor tasks in patients with schizophrenia. Psychiatry Res (2004) 0.85
Possible interaction between MAOA and DRD2 genes associated with antisocial alcoholism among Han Chinese men in Taiwan. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.85
Long-acting injectable antipsychotics for first-episode schizophrenia: the pros and cons. Schizophr Res Treatment (2012) 0.85
The DRD2/ANKK1 gene is associated with response to add-on dextromethorphan treatment in bipolar disorder. J Affect Disord (2012) 0.85
Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study. Am J Psychiatry (2004) 0.85
Correlation between different memory systems and striatal dopamine D2/D3 receptor density: a single photon emission computed tomography study. Psychol Med (2005) 0.84
The association between DRD2/ANKK1, 5-HTTLPR gene, and specific personality trait on antisocial alcoholism among Han Chinese in Taiwan. Am J Med Genet B Neuropsychiatr Genet (2008) 0.84
Association of novelty seeking scores and striatal dopamine D₂/D₃ receptor availability of healthy volunteers: single photon emission computed tomography with ¹²³i-iodobenzamide. J Formos Med Assoc (2010) 0.83
Correlation between striatal dopamine D2 receptor density and neuroticism in community volunteers. Psychiatry Res (2005) 0.83
The ALDH2 and 5-HT2A genes interacted in bipolar-I but not bipolar-II disorder. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.83
The profile and familiality of personality traits in mood disorder families. J Affect Disord (2012) 0.83
Availability of dopamine and serotonin transporters in opioid-dependent users--a two-isotope SPECT study. Psychopharmacology (Berl) (2011) 0.83
Norms of performance of sustained attention among a community sample: Continuous Performance Test study. Psychiatry Clin Neurosci (2005) 0.83
Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder. J Psychiatr Res (2013) 0.83
Verapamil protects dopaminergic neuron damage through a novel anti-inflammatory mechanism by inhibition of microglial activation. Neuropharmacology (2010) 0.83